Waters Adds Fusion Method Development Software from S-Matrix to Automate LC Method Development
14 Dec 2009Waters Corporation has become the exclusive distributor of Fusion Method Development™ software, developed by S-Matrix® Corporation. The software works seamlessly with Waters® Empower® 2 chromatography data software (CDS) and ACQUITY UltraPerformance LC® (UPLC®) to automate liquid chromatographic method development according to Quality-by-Design (QbD) guidelines.
Using a QbD-based methodology for LC method development allows scientists to develop the best possible method much faster and with much greater confidence. Fusion works with Empower 2 and ACQUITY® UPLC to increase lab efficiency by designing statistically valid experiments and automatically reconstructing them in Empower 2 as fully ready-to-run sequences. Fusion uses the resulting data to generate parameter-effects models which establish the final design and operating spaces for truly optimized LC methods. This automated process ensures that scientists develop the right method the first time and translate chromatographic data into information, knowledge and answers. Recent work1, conducted at a large pharmaceutical company, to benchmark the effectiveness of Fusion Method Development used in combination with Empower 2 and ACQUITY UPLC, demonstrated that it was possible to reduce method development time for a complex drug product from 45-60 days to two days when compared to the conventional one-factor-at-a-time development approach.
Fusion Method Development also addresses regulatory recommendations to incorporate robustness into LC method development (ICH Q2B Validation of Analytical Procedures – Methodology). Utilizing a patented approach built on sound statistical process control techniques, the software computes and models the impact of key chromatographic parameters on method robustness. This enables identification of methods optimized for both mean performance and robustness without the need for any additional experiments. Establishing the final design space for a method in this manner creates the basis for regulatory flexibility and continuous improvement (ICH Q8(R1) Pharmaceutical Development).
Use of Fusion Method Development software crosses virtually all laboratories served by LC, including pharmaceutical, food & beverage, fine chemicals, and environmental labs. More information on Fusion in combination with Empower 2 and ACQUITY UPLC is available by following the Company article page link top right of this page.
Related Products
Request Quote for All Products
ACQUITY UPLC System
WatersWaters ACQUITY UPLC - Dramatic Improvements in Speed, Sensitivity and Resolution Whether you work in methods development or quality assurance, in drug discovery and development or testing for safety in food supplies, you seek a productivity edge. With the ACQUITY UPLC® System, now you can get more information in a single, short run than you've ever seen with HPLC. Waters ACQUITY UPLC System UltraPerformance LC® (UPLC®) technology starts with unique 1.7 μm small-particle chemistries. Chromatographers no longer need to choose between speed and resolution–with UPLC you get both. Instrument Designed for Chemistry; Chemistry Designed for the Instrument The ACQUITY UPLC System has been holistically designed to match the performance needs of our innovative column chemistries with robust hardware, easy-to-use software and specialized support services. Small, pressure-tolerant particles High-pressure fluidic modules Minimized system volume Negligible carryover Reduced cycle times Fast response detectors Integrated system software and diagnostics With UPLC you have the ability to work more efficiently with higher speed, sensitivity and resolution at a much wider range of linear velocities, flow rates and backpressures to obtain superior results. The Waters ACQUITY UPLC System's high-pressure fluidics optimizes flow rates to make the most of small particle technology. The ACQUITY UPLC System's sample-handling design is designed to ensure exceptionally low carryover and reduced cycle time. And when interfaced with the Sample Organizer, it increases unattended sample capacity by ten times. High-speed detectors, both optical and mass, contribute to increased sensitivity and help manage the heightened speed and resolution requirements of UPLC. ACQUITY UPLC Systems are easily controlled, diagnosed, and monitored via a graphical system console interface. The console offers: Quick and easy access to critical instrument parameters Simple system start-up, elegant system status monitoring and predictive performance indicators to ensure maximum productivity Data management capabilities that are supported by both MassLynx™ and Empower™ software The ACQUITY UPLC System is also supported by Intelligent Device Management technology with our Connections® INSIGHT™ service, providing instrument diagnostics.